TN2010000599A1 - Compositions and methods of use for therapeutic antiodies - Google Patents
Compositions and methods of use for therapeutic antiodiesInfo
- Publication number
- TN2010000599A1 TN2010000599A1 TNP2010000599A TN2010000599A TN2010000599A1 TN 2010000599 A1 TN2010000599 A1 TN 2010000599A1 TN P2010000599 A TNP2010000599 A TN P2010000599A TN 2010000599 A TN2010000599 A TN 2010000599A TN 2010000599 A1 TN2010000599 A1 TN 2010000599A1
- Authority
- TN
- Tunisia
- Prior art keywords
- compositions
- methods
- antibodies
- antiodies
- therapeutic
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Antibodies that specifically bind to the BAFF receptor (BAFFR). More specifically antibodies that are BAFFR antagonists with in vivo B cell depleting activity and compositions and methods of use for said antibodies to treat pathological disorders that can be treated by killing or depleting B cells, such as systemic lupus erythematosus or rheumatoid arthritis or other autoimmune diseases or lymphomas, leukemias and myelomas.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP2009/059030 WO2010007082A1 (en) | 2008-07-17 | 2009-07-15 | Compositions and methods of use for therapeutic antibodies |
Publications (1)
Publication Number | Publication Date |
---|---|
TN2010000599A1 true TN2010000599A1 (en) | 2012-05-24 |
Family
ID=55024674
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TNP2010000599A TN2010000599A1 (en) | 2009-07-15 | 2010-12-24 | Compositions and methods of use for therapeutic antiodies |
Country Status (1)
Country | Link |
---|---|
TN (1) | TN2010000599A1 (en) |
-
2010
- 2010-12-24 TN TNP2010000599A patent/TN2010000599A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY158980A (en) | Compositions and methods of use for therapeutic antibodies | |
PH12015500276A1 (en) | Treatment of immune-related and inflammatory diseases | |
IL256110A (en) | Compositions comprising cd19xcd3 bispecific antibodies for the treatment of tumorous mass of lymph node tissue and/or extranodal lymphoma caused by diffuse large b cell lymphoma (dlbcl) | |
PH12014502698B1 (en) | Improved antagonist antibodies against gdf-8 and uses therefor | |
MX2013006040A (en) | Lysophosphatidic acid receptor antagonists and their use in the treatment fibrosis. | |
GB0906579D0 (en) | Pharmaceuticals, compositions and methods of making and using the same | |
MX2019008122A (en) | Heterocycle amines and uses thereof. | |
MX2019007492A (en) | T cell receptor-deficient t cell compositions. | |
MY163055A (en) | Polycyclic antagonists of lysophosphatidic acid receptors | |
TN2012000126A1 (en) | Polycyclic compounds as lysophosphatidic acid receptor antagonists | |
IN2012DN02735A (en) | ||
IN2012DN00754A (en) | ||
JO3267B1 (en) | DISUBSTITUTED OCTAHYDROPYRROLO[3,4-c]PYRROLES AS OREXIN RECEPTOR MODULATORS | |
MX2011011338A (en) | Composition and methods of use for therapeutic antibodies specific for the il-12 receptore betal subunit. | |
IN2012DN06588A (en) | ||
WO2011047058A3 (en) | Assay for the prediction of therapeutic effectiveness of mesenchymal stromal cells, and methods of using same | |
UA103624C2 (en) | Antibody for a target baffr polypeptide | |
TN2010000599A1 (en) | Compositions and methods of use for therapeutic antiodies | |
WO2009108635A3 (en) | Novel compositions for treatment of diseases related to activated lymphocytes |